BioCryst Pharmaceuticals (BCRX): Q2 EPS of -$0.25 beats by $0.01. Revenue of $4.2M (+13.5% Y/Y)...

|About: BioCryst Pharmaceuticals... (BCRX)|By:, SA News Editor
BioCryst Pharmaceuticals (BCRX): Q2 EPS of -$0.25 beats by $0.01. Revenue of $4.2M (+13.5% Y/Y) misses by $1.2M. (PR)